Axsome Therapeutics Inc (NASDAQ:AXSM)

44.73
BATS BZX Real-Time Price
As of 9:38am ET
 +0.54 / +1.22%
Today’s Change
20.63
Today|||52-Week Range
71.98
+18.40%
Year-to-Date
2 No-Brainer Biotech Stocks to Buy Right Now
Sep 26 / MotleyFool.com - Paid Partner Content
2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
Sep 22 / MotleyFool.com - Paid Partner Content
3 Monster Stocks in the Making
Sep 24 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Could Make You Richer
Sep 17 / MotleyFool.com - Paid Partner Content
If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today
Sep 23 / MotleyFool.com - Paid Partner Content
Is It Too Late to Buy Axsome Therapeutics Stock?
Sep 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close44.19
Today’s open46.56
Day’s range43.95 - 44.73
Volume1,409
Average volume (3 months)1,651,840
Market cap$2.0B
Data as of 9:38am ET, 09/30/2022

Growth & Valuation

Earnings growth (last year)-25.34%
Earnings growth (this year)-24.53%
Earnings growth (next 5 years)+1.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book121.60

Competitors

----
SAVACassava Sciences Inc-0.01-0.02%
RCUSArcus Biosciences In...+0.41+1.61%
----
Data as of 9:38am ET, 09/30/2022

Financials

Next reporting dateNovember 10, 2022
EPS forecast (this quarter)-$1.08
Annual revenue (last year)$0.00
Annual profit (last year)-$130.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts